Dopamine and frusemide in oliguric acute renal failure

Nephron. 1984;37(1):39-42. doi: 10.1159/000183205.

Abstract

Into 24 oliguric patients with acute renal failure (ARF) for whom mannitol and high-dose frusemide had failed to promote a diuresis, dopamine (3 micrograms/kg/min) plus frusemide (10-15 mg/kg/h) were infused for 6-24 h. In 19 of the 24 patients this treatment produced significant increases in diuresis (from 11 +/- 7 to 85 +/- 51 ml/h; p less than 0.001) and natriuresis (from 45 +/- 13 to 88 +/- 22 mEq/1; p less than 0.001), without any significant modification of blood pressure, pulse rate or central venous pressure. 10 of the 24 patients required dialysis: 5 because therapy failed to promote diuresis and the other 5 because of their hypercatabolic state in spite of polyuria. 5 patients died of causes unrelated to ARF. Since all patients who responded were treated within 24 h after the onset of oliguria, it appears to be crucial to administer dopamine and frusemide early, before more severe anatomical and functional damage develops.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Adult
  • Aged
  • Anuria / drug therapy*
  • Diuresis / drug effects
  • Dopamine / administration & dosage
  • Dopamine / therapeutic use*
  • Drug Therapy, Combination
  • Furosemide / administration & dosage
  • Furosemide / therapeutic use*
  • Humans
  • Middle Aged
  • Natriuresis / drug effects
  • Oliguria / drug therapy*

Substances

  • Furosemide
  • Dopamine